J Med Microbiol Track the topics, authors and articles important to you
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nagel, J.
Right arrow Articles by Poot-Scholtens, E. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nagel, J.
Right arrow Articles by Poot-Scholtens, E. J.
Agricola
Right arrow Articles by Nagel, J.
Right arrow Articles by Poot-Scholtens, E. J.

The Journal of Medical Microbiology, Vol 16, Issue 4 417-426, Copyright © 1983 by Society for General Microbiology

JOURNAL ARTICLE

Serum IgA antibody to Bordetella pertussis as an indicator of infection

J. Nagel and E. J. Poot-Scholtens

The levels of pertussis-specific IgA antibodies in sera from vaccinees and from children with Bordetella pertussis infection were compared by an enzyme-linked immunosorbent assay (ELISA). Serum IgA antibodies were produced only after natural contact with the pathogen and, therefore, their presence can be used as an indicator of infection. However, in view of the relatively long interval between infection and the appearance of antibodies, and the prolonged antibody response, their presence cannot be used as proof of recent infection. The finding of these antibodies in a high percentage of the normal adult population may indicate a constant circulation of B. pertussis without symptoms of disease.


This article has been cited by other articles:


Home page
 Clin. Microbiol. Rev.Home page
S. Mattoo and J. D. Cherry
Molecular Pathogenesis, Epidemiology, and Clinical Manifestations of Respiratory Infections Due to Bordetella pertussis and Other Bordetella Subspecies
Clin. Microbiol. Rev., April 1, 2005; 18(2): 326 - 382.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
M. Hijnen, F. R. Mooi, P. G. M. van Gageldonk, P. Hoogerhout, A. J. King, and G. A. M. Berbers
Epitope Structure of the Bordetella pertussis Protein P.69 Pertactin, a Major Vaccine Component and Protective Antigen
Infect. Immun., July 1, 2004; 72(7): 3716 - 3723.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
M. E. Rodriguez, S. M. M. Hellwig, D. F. Hozbor, J. Leusen, W. -L. van der Pol, and J. G. J. van de Winkel
Fc Receptor-Mediated Immunity Against Bordetella pertussis
J. Immunol., December 1, 2001; 167(11): 6545 - 6551.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
S. M. M. Hellwig, A. B. van Spriel, J. F. P. Schellekens, F. R. Mooi, and J. G. J. van de Winkel
Immunoglobulin A-Mediated Protection against Bordetella pertussis Infection
Infect. Immun., August 1, 2001; 69(8): 4846 - 4850.
[Abstract] [Full Text] [PDF]

Home page
 PediatricsHome page
C. C. Grant, E. J. McKay, D. M. Sci, A. Simpson, and D. Buckley
Pertussis Encephalopathy With High Cerebrospinal Fluid Antibody Titers to Pertussis Toxin and Filamentous Hemagglutinin
Pediatrics, October 1, 1998; 102(4): 986 - 989.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
INT J SYST EVOL MICROBIOL J MED MICROBIOL MICROBIOLOGY J GEN VIROL ALL SGM JOURNALS
Copyright © 1983 Society for General Microbiology.